Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Change in Inventory (2017 - 2019)

Ironwood Pharmaceuticals (IRWD) has disclosed Change in Inventory for 7 consecutive years, with $451000.0 as the latest value for Q3 2019.

  • Quarterly Change in Inventory rose 261.65% to $451000.0 in Q3 2019 from the year-ago period, while the trailing twelve-month figure was $934000.0 through Dec 2020, changed N/A year-over-year, with the annual reading at -$648000.0 for FY2020, N/A changed from the prior year.
  • Change in Inventory hit $451000.0 in Q3 2019 for Ironwood Pharmaceuticals, down from $483000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $768000.0 in Q1 2018 to a low of -$1.0 million in Q2 2017.
  • Historically, Change in Inventory has averaged $140181.8 across 4 years, with a median of $152000.0 in 2019.
  • Biggest five-year swings in Change in Inventory: crashed 100.32% in 2015 and later surged 1181.69% in 2018.
  • Year by year, Change in Inventory stood at -$4000.0 in 2015, then surged by 18475.0% to $735000.0 in 2017, then tumbled by 87.35% to $93000.0 in 2018, then soared by 384.95% to $451000.0 in 2019.
  • Business Quant data shows Change in Inventory for IRWD at $451000.0 in Q3 2019, $483000.0 in Q2 2019, and $152000.0 in Q1 2019.